Lockitt.
I am sure there would be very practical reasons why RB is still there after his demotion.
His contract read a 6 month notice period, simple we are not going to pay him six months wages to let him walk. He is required to spend that in the office doing something meaningful towards INCA. He owes shareholder that he has for 12 years received a very lucrative package and lived a good life based in Perth.
He very well would have liked a payout, but thats not going to happen.
RB holds a lot of knowledge paid for by shareholders and also he himself although not having a great deal of shares needs to see it out and be constructive about it due his own financial gain from his shares which whilst there he received from salary sacrifice and some bonus performance rights and a few he was embarrassed onto buying during capital raises by JW.
Prior to JW both RB & GL had nil or little skin in the game, only from pressure during Capital raises were they pushed to actually bare some load. Each took minimal and then didn't expand when Options were called only purchased allotted amount.
We don't owe GL anything he can go no cost, but its my understanding only that under ASX ruling we require the third director. For what he does I will take his job I am a T10 holder and could do with the money but I don't wear fancy suits.
If I look at last annual meeting shares holders list I am above T10 status although unknown now due some increase in % of T20 but I have been buying to this date so it could be me raising the % of T20 but I don't think I am alone. I note the directors % has not changed but the t20 group has risen.
Hold tight Alpaca
Both GL & RB are not T20 holders.
- Forums
- ASX - By Stock
- ICG
- Ann: Maiden Australian Drill Program Successfully Completed
ICG
inca minerals limited
Add to My Watchlist
0.00%
!
0.8¢

Ann: Maiden Australian Drill Program Successfully Completed, page-25
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.61M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $2.14K | 267.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 643091 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 4380274 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 543091 | 0.008 |
12 | 4569047 | 0.007 |
12 | 5272455 | 0.006 |
12 | 4109603 | 0.005 |
6 | 3217588 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 4380274 | 4 |
0.010 | 3114283 | 8 |
0.011 | 825666 | 3 |
0.014 | 1033333 | 2 |
0.015 | 2043906 | 6 |
Last trade - 14.10pm 27/06/2025 (20 minute delay) ? |
Featured News
ICG (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online